68 related articles for article (PubMed ID: 9206209)
1. [The role of platelet-derived growth factor and ras P21 in experimental hepatocarcinogenesis].
Zheng J; Ruan Y; Liu B
Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):79-82. PubMed ID: 9206209
[TBL] [Abstract][Full Text] [Related]
2. [The influence of Kupffer cells on experimental hepatocarcinogenesis].
Zhu H; Ruan Y; Wu Z
Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):102-4. PubMed ID: 11244957
[TBL] [Abstract][Full Text] [Related]
3. [In situ expression of c-myc, N-ras during diethylnitrosamine induced hepatocarcinogenesis].
Zheng J; Wu Z; Ruan Y
Zhonghua Bing Li Xue Za Zhi; 1995 Oct; 24(5):309-11. PubMed ID: 8745481
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of c-Ha-ras oncogene p21 product in pre-neoplastic and neoplastic lesions during hepatocarcinogenesis in rats.
Galand P; Jacobovitz D; Alexandre K
Int J Cancer; 1988 Jan; 41(1):155-61. PubMed ID: 3275589
[TBL] [Abstract][Full Text] [Related]
5. Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis.
Maass T; Thieringer FR; Mann A; Longerich T; Schirmacher P; Strand D; Hansen T; Galle PR; Teufel A; Kanzler S
Int J Cancer; 2011 Mar; 128(6):1259-68. PubMed ID: 20506153
[TBL] [Abstract][Full Text] [Related]
6. [Expression of rasp21, C-myc, C-erbB-2, and AFP in 2-FAA induced experimental hepatocarcinogenesis].
Shi G; Sun C; Han X; Meng X; Wang M; Gu M
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):98-9. PubMed ID: 11350689
[TBL] [Abstract][Full Text] [Related]
7. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
Coltrera MD; Wang J; Porter PL; Gown AM
Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
[TBL] [Abstract][Full Text] [Related]
8. Quantitative and/or qualitative changes in the p21-H-ras post-translational products in regenerating liver and during hepatocarcinogenesis.
Gulbis B; Alexandre K; Galand P
Int J Cancer; 1993 Nov; 55(5):837-40. PubMed ID: 8244581
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
10. Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism.
Potapova O; Fakhrai H; Mercola D
Int J Cancer; 1996 May; 66(5):669-77. PubMed ID: 8647631
[TBL] [Abstract][Full Text] [Related]
11. Alterations in enzymatic functions in hepatocytes and hepatocellular carcinomas from Ras-transduced livers resemble the effects of insulin.
Pearline RV; Lin YZ; Shen KJ; Brunt EM; Bowling WM; Hafenrichter DG; Kennedy S; Flye MW; Ponder KP
Hepatology; 1996 Oct; 24(4):838-48. PubMed ID: 8855186
[TBL] [Abstract][Full Text] [Related]
12. [Correlation study of TGF beta expression in diethylnitrosamine-induced rat liver cancer and mast cells in its vicinity].
Zheng M; Ruan Y; Wu Z
Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):463-5. PubMed ID: 11235564
[TBL] [Abstract][Full Text] [Related]
13. Modulation by indomethacin of diethylnitrosamine-induced early changes in c-myc and c-ras expression and late incidence of preneoplastic lesions in rat liver.
Servais P; Taton G; Galand P
Carcinogenesis; 1990 Aug; 11(8):1433-6. PubMed ID: 2201456
[TBL] [Abstract][Full Text] [Related]
14. Normal developing rat brain expresses a platelet-derived growth factor B chain (c-sis) mRNA truncated at the 5' end.
Sasahara M; Amano S; Sato H; Yang JG; Hayase Y; Kaneko M; Sato I; Suzaki M; Hazama F
Oncogene; 1998 Mar; 16(12):1571-8. PubMed ID: 9569024
[TBL] [Abstract][Full Text] [Related]
15. Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicyclic acid: association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis.
Stärkel P; Charette N; Borbath I; Schneider-Merck T; De Saeger C; Abarca J; Leclercq I; Horsmans Y
Mol Carcinog; 2012 Oct; 51(10):816-25. PubMed ID: 21882255
[TBL] [Abstract][Full Text] [Related]
16. A role for activated p21 ras in inhibition/regulation of platelet-derived growth factor (PDGF) type-beta receptor activation.
Zubiaur M; Forman LW; Stice LL; Faller DV
Oncogene; 1996 Mar; 12(6):1213-22. PubMed ID: 8649823
[TBL] [Abstract][Full Text] [Related]
17. smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells.
Sakoda T; Kaibuchi K; Kishi K; Kishida S; Doi K; Hoshino M; Hattori S; Takai Y
Oncogene; 1992 Sep; 7(9):1705-11. PubMed ID: 1323817
[TBL] [Abstract][Full Text] [Related]
18. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus.
Uhrbom L; Hesselager G; Nistér M; Westermark B
Cancer Res; 1998 Dec; 58(23):5275-9. PubMed ID: 9850047
[TBL] [Abstract][Full Text] [Related]
19. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
[TBL] [Abstract][Full Text] [Related]
20. NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo.
Kumar S; Kahn MA; Dinh L; de Vellis J
J Neurosci Res; 1998 Dec; 54(6):754-65. PubMed ID: 9856859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
